Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implications
- PMID: 17940421
- PMCID: PMC6736533
- DOI: 10.1097/MED.0b013e328012d605
Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implications
Abstract
Purpose of review: The purpose of this review is to highlight the importance of pituitary adenylate cyclase-activating polypeptide in physiological processes and to describe how this peptide is becoming increasingly recognized as having a major role in the body. Since its discovery in 1989, investigators have sought to determine the site of biological activity and the function of pituitary adenylate cyclase-activating polypeptide in maintaining homeostasis.
Recent findings: Since its discovery, pituitary adenylate cyclase-activating polypeptide appears to play an important role in the regulation of processes within the central nervous system and gastrointestinal tract, as well in reproductive biology. Pituitary adenylate cyclase-activating polypeptide has been shown to regulate tumor cell growth and to regulate immune function through its effects on T lympocytes. These discoveries suggest the importance of pituitary adenylate cyclase-activating polypeptide in neuronal development, neuronal function, gastrointestinal tract function and reproduction.
Summary: Future studies will examine more closely the role of pituitary adenylate cyclase-activating polypeptide in regulation of malignantly transformed cells, as well as in regulation of immune function.
Figures

Similar articles
-
Pituitary adenylate cyclase-activating polypeptide (PACAP) in the hypothalamic-pituitary-gonadal axis: a review of the literature.Reprod Sci. 2013 Aug;20(8):857-71. doi: 10.1177/1933719112466310. Epub 2012 Dec 10. Reprod Sci. 2013. PMID: 23232965 Review.
-
Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats.Mol Pain. 2017 Jan-Dec;13:1744806917720361. doi: 10.1177/1744806917720361. Mol Pain. 2017. PMID: 28776455 Free PMC article.
-
Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract.Neuroscience. 1998 Apr;83(4):1261-72. doi: 10.1016/s0306-4522(97)00474-0. Neuroscience. 1998. PMID: 9502264
-
Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.J Neurochem. 2007 Nov;103(3):1157-67. doi: 10.1111/j.1471-4159.2007.04813.x. Epub 2007 Aug 6. J Neurochem. 2007. PMID: 17680996
-
Growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide in the reproductive system.Trends Endocrinol Metab. 2002 Dec;13(10):428-35. doi: 10.1016/s1043-2760(02)00632-x. Trends Endocrinol Metab. 2002. PMID: 12431839 Review.
Cited by
-
VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):61-7. doi: 10.1097/MED.0b013e328342568a. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21157320 Free PMC article. Review.
-
PACAP and VIP Neuropeptides' and Receptors' Effects on Appetite, Satiety and Metabolism.Biology (Basel). 2023 Jul 17;12(7):1013. doi: 10.3390/biology12071013. Biology (Basel). 2023. PMID: 37508442 Free PMC article. Review.
-
PACAP has anti-apoptotic effect in the salivary gland of an invertebrate species, Helix pomatia.J Mol Neurosci. 2008 Nov;36(1-3):105-14. doi: 10.1007/s12031-008-9070-x. Epub 2008 May 13. J Mol Neurosci. 2008. PMID: 18473188
-
Positive allosteric regulation of PAC1-R up-regulates PAC1-R and its specific ligand PACAP.Acta Biochim Biophys Sin (Shanghai). 2022 May 25;54(5):657-672. doi: 10.3724/abbs.2022041. Acta Biochim Biophys Sin (Shanghai). 2022. PMID: 35593471 Free PMC article.
-
Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):38-47. doi: 10.1097/MED.0000000000000218. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 26702849 Free PMC article. Review.
References
-
- Miyata A, Arimura A, Dahl RR, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164:567–574. - PubMed
-
- Vaudry D, Gonzalez BJ, Basille M, et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 2000; 52:269–324. - PubMed
-
- Arimura A Pituitary adenylate cyclase-activating polypeptide (PACAP): discovery and status of current research. Reg Peptides 1992; 37:287–303. - PubMed
-
- Koves K, Arimura A, Gorcs TG, Somogyvari-Vigh A. Comparative distribution of immunoreactive pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology 1991; 54:159–169. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials